Related Bits of Random Stuff:
"One in seven UK based scientists or doctors has witnessed colleagues intentionally altering or fabricating data during their research or for the purposes of publication." - British Medical Journal, Britain
Bloodless surgery got a shot in the arm this past January when New Jersey Congressman Steve Rothman announced the latest batch of federal funds, $1.49 million, for the Institute for Patient Blood Management and Bloodless Medicine and Surgery at the Englewood Hospital and Medical Center.
This brings the total amount of federal funding secured by Congressman Rothman for this institute to $4.69 million in federal resources and to over six million dollars to Hospital programs since 2002. This project will provide instruction and training for military and civilian physicians and other healthcare providers seeking to implement improved patient blood management strategies. The program, run through the U.S. Army/Medical Research & Materiel Command (USAMRC), will be particularly useful during conflicts or natural disaster when blood is often limited or unavailable. Project participants are not only taught procedures in blood management, but also receive training in how to teach blood management strategies and use available resources as well as how to collect data. This will prepare participants to manage and lead their own blood management efforts.
"I am very happy to deliver this latest batch of federal funds from Washington, DC, $1.49 million, to Englewood Hospital and Medical Center (EHMC). This now brings the total for the Hospital's bloodless medicine program to $4.69 million and for all EHMC programs I was able to secure over six million in federal dollars that I have brought home since 2002. These resources were appropriated for the hospital's breast care center, emergency room, radiology information system, and the Institute for the Advancement of Bloodless Medicine. Englewood Hospital does such important work and I look forward to continuing to help," said Congressman Rothman.
"Receiving this funding is an honor for Englewood Hospital and a confirmation of our status as a world leader in the practice of bloodless medicine and surgery," said Douglas A. Duchak, President and CEO of the Medical Center. "For a community hospital to receive this recognition is a remarkable achievement. I thank Congressman Steve Rothman for securing these much needed funds - without his support this program would not be possible. Congressman Rothman has taken strong leadership on this issue and throughout his career. The people of the Ninth Congressional District and Englewood Hospital could not ask for a better representative in Washington, DC."
Aryeh Shander, MD, Chief of Anesthesiology, Critical Care Medicine, Pain Management and Hyperbaric Medicine at Englewood Hospital and Executive Medical Director of its Institute for Patient Blood Management and Bloodless Medicine and Surgery, who will also speak at today's event, explained the rationale that's driving the project. "While there are clear situations where blood transfusions are necessary, there are many reasons why unneeded transfusions are risky and should be avoided," he notes.
Risks of blood transfusion include infectious and noninfectious complications. In addition, ample data suggests that transfusions are also associated with increased mortality. Also, the cost of blood transfusion continues to rise due to increased testing for infectious agents. In combat situations and other disasters, blood often is not available or in short supply, underscoring the need for blood management.
In partnership with the DOD, Englewood Hospital's Institute for Patient Blood Management and Bloodless Medicine and Surgery will work to achieve the following outcomes:
Since its inception in 1994, The Institute for Patient Blood Management & Bloodless Medicine and Surgery at Englewood Hospital and Medical Center has established itself as a world-recognized leader in patient blood management. Physicians from every discipline have been specially trained and practice bloodless medicine and surgery at the Institute. More than 50,000 patients from the U.S. and abroad have received medical treatment and undergone highly complex procedures such as brain, open-heart, orthopedic, and gastrointestinal surgeries without blood transfusions at Englewood Hospital. Medical professionals from leading institutions across the country and throughout the world have come to the Medical Center to learn how its physicians use proven, effective alternatives to blood transfusion to improve patient outcomes.
An affiliate of the Mount Sinai School of Medicine, Englewood Hospital and Medical Center provides patients with the highest level of compassionate care through a broad range of state-of-the-art clinical programs offering the most advanced treatments and diagnostic services. Through its affiliation with Mt. Sinai, this thriving acute-care and community teaching hospital hosts medical residents in a variety of disciplines, including surgery, paediatrics, podiatry, pathology, and critical care medicine and is home to a Vascular Fellowship Program that has trained a generation of world-class vascular surgeons. The Medical Center is renowned for its patient blood management and cardiac and vascular programs and is a leader in breast care, oncology, and joint replacement services. Many members of the medical staff of Englewood Hospital, a member of Mt. Sinai Consortium for Medical Education, serve as faculty members at Mt. Sinai. Englewood Hospital and Medical Center has earned numerous accreditations from the Joint Commission and other organizations and is among the four percent of hospitals nationwide honored with the prestigious Magnet nursing award, a distinction is has earned twice.